1. Home
  2. Live Updates
  3. தேசிய ஆஸ்துமா வழிகாட்டுதல்கள்

தேசிய ஆஸ்துமா வழிகாட்டுதல்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from தேசிய ஆஸ்துமா வழிகாட்டுதல்கள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In தேசிய ஆஸ்துமா வழிகாட்டுதல்கள் Today - Breaking & Trending Today

Business Scoop » Scientifically-backed Health App To Help People With Asthma Struggles To Secure Ministry Funding


Press Release – Asthma and Respiratory Foundation of New Zealand
The Asthma and Respiratory Foundation NZ (ARFNZ) is disappointed that the Ministry of Health has not confirmed funding for an app that could improve the lives of the 700,000 Kiwis living with respiratory disease. ARFNZ launched the MyAsthma app in …
The Asthma and Respiratory Foundation NZ (ARFNZ) is disappointed that the Ministry of Health has not confirmed funding for an app that could improve the lives of the 700,000 Kiwis living with respiratory disease.
ARFNZ launched the MyAsthma app in 2017, to provide information and basic tools to help people manage their asthma. Recently, the app was reviewed by Health Navigator NZ, and along with feedback from ARFNZ’s Scientific Advisory Board and the general public, this highlighted areas for improvement. The app needs to be redeveloped and enhanced to give patients the ability to fully track and record their daily symptoms, peak flow readings and medic ....

New Zealand , New Zealanders , James Fingleton , Joanna Turner , Letitia Harding , Health Navigator , Foundation Of New Zealand , National Asthma Guidelines , Ministry Of Health , Press Release , Respiratory Foundation , Advisory Board , Executive Letitia , Director Dr James , Education Manager Joanna , Scientific Advisory Board , புதியது ஜீலாந்து , ஜேம்ஸ் விரல் , ஜொவந டர்னர் , லீடிஶிய கடினப்படுத்துதல் , ஆரோக்கியம் நேவிகேட்டர் , அடித்தளம் ஆஃப் புதியது ஜீலாந்து , தேசிய ஆஸ்துமா வழிகாட்டுதல்கள் , அமைச்சகம் ஆஃப் ஆரோக்கியம் , ப்ரெஸ் வெளியீடு , சுவாச அடித்தளம் ,

Scientifically-backed Health App To Help People With Asthma Struggles To Secure Ministry Funding

Scientifically-backed Health App To Help People With Asthma Struggles To Secure Ministry Funding
scoop.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from scoop.co.nz Daily Mail and Mail on Sunday newspapers.

New Zealand , New Zealanders , James Fingleton , Joanna Turner , Letitia Harding , Citizen Community , Foundation For Public Interest Journalism , Health Navigator , Foundation Of New Zealand , National Asthma Guidelines , Ministry Of Health , Foundation Of New Zealand On Infopages , Respiratory Foundation , Advisory Board , Executive Letitia , Director Dr James , Education Manager Joanna , Scientific Advisory Board , Scoop Citizen Community , In Depth Engaged Journalism , Scoop Foundation , Public Interest Journalism , புதியது ஜீலாந்து , ஜேம்ஸ் விரல் , ஜொவந டர்னர் , லீடிஶிய கடினப்படுத்துதல் ,

Investegate |AstraZeneca PLC Announcements | AstraZeneca PLC: Symbicort approved in China for mild asthma


 
an anti-inflammatory reliever in mild asthma
 
therapy approved in China for mild, moderate and severe asthma
 
AstraZeneca s Symbicort Turbuhaler (budesonide/formoterol 160/4.5mcg) has been approved in China as an anti-inflammatory reliever to be taken as-needed in response to symptoms to achieve asthma control in patients with mild asthma aged 12 years and older.
 
The approval by the National Medical Products Administration (NMPA) was based on positive results from the
SYGMA 1
and
SYGMA 2
Phase III trials, published in TheNew England Journal of Medicine, which evaluated the efficacy of Symbicort Turbuhaler taken as-needed as an anti-inflammatory reliever compared with standard of care (SoC) therapies in mild asthma. SoC included short-acting beta2-agonist (SABA) taken as-needed or regular maintenance controller therapy (twice-daily budesonide, an inhaled corticosteroi ....

United Kingdom , United States , Symbicort Turbuhaler , Buhlr Budesonide , Astrazeneca Symbicort Turbuhaler , Adrian Kemp , Astrazeneca Pharmaceuticals , Chinese Thoracic Society , International Study Group , Company On Twitter Astrazeneca , China Thoracic Society , Investor Relations Team , National Asthma Guidelines , National Medical Products Administration , Global Asthma Network , Blood Institute , National Heart , Global Initiative For Asthma , Thenew England Journal , Vice President , Shanghai General Hospital , Global Initiative , Executive Vice President , Symbicort Given , Mild Asthma , New England Journal ,